Q. What’s the whole deal with Gla residues, vitamin K and the Coumadin drugs?
A. Great question! I get the best questions from our readers – thank you.
First, a little review of a pertinent part of coagulation. In order to bind calcium (which is a critical part of coagulation), several proteins involved in coagulation need to be carboxylated. These are called vitamin-K-dependent (for reasons we’ll talk about in a second) coagulation factors, and you should commit them to memory: factors II, VII, IX, and X and proteins C and S. Carboxylation happens at glutamate residues, and the new, carboxylated residues are called gamma-carboxyglutamate residues (abbreviated GLA residues).
These factors are vitamin-K-dependent because Vitamin K is the thing that performs the carboxylation. As it does so, it becomes oxidized, and has to be converted back into a reduced state before it can be used again. The enzyme that recycles vitamin K from its oxidized state back to its reduced state is called Vitamin K epoxide reductase.
Now, on to warfarin (Coumadin). Warfarin is sometimes referred to as a vitamin K antagonist because it inhibits the vitamin-K-dependent factors (listed above). It does so by inhibiting vitamin K epoxide reductase, thus preventing the recycling of vitamin K, and the carboxylation of the vitamin-K-dependent factors. It takes a while to see the effects of warfarin, because at the time you give the drug, you have normal (carboxylated) factors II, VII, IX and X around. These normal factors disappear after a while, though. Of all of these factors, the one with the shortest half life is factor VII. That’s why we use the INR (which measures the extrinsic pathway of coagulation) to monitor patients on warfarin therapy. You could also use the PTT – but by the time the factors on that side of the pathway are decreased, your patient might be over-anti-coagulated.
Tagsacute leukemia acute lymphoblastic leukemia acute myeloid leukemia acute promyelocytic leukemia Add new tag anemia b cells blood smear bone marrow brain tumors carcinoma cases chronic myelofibrosis chronic myeloid leukemia chronic myeloproliferative disorders coagulation cortisol cytochemistry cytogenetics essential thrombocythemia heart hemophilia immunology infection inflammation kaplan kidney laboratory tests lymphocyte lymphocytes lymphoma macrophages neoplasia neutrophil normal photoblog polycythemia vera red blood cells red cells sickle cell anemia skin squamous cell carcinoma stains student questions t cells
- Mohini Jayant Dave said I usually first write down what I have to say and then makes slides of valid points which I may forg...
- Chimezie Okwuonu said Good explanation. Quite clear. Am impressed
- aamir hasnain said thanx very clear and concise
- Dr. Abdul Karim Affouni said Super thanx for such friendly informative description.
- PASCUAL OC said MUCHAS GRACIAS, TODO SEA EN PRO DE LA CIENCIA!
- maram said thank you for the help
- Muthuselvi said Very good information !!!!!thanks a lot …..
- alem teka said thank you v/much
- usama said thanks soooooo much
- vidya said In APLA syndrome where there is not much chance for clotting how does thrombosis occur???( thrombosi...
- jumana haque said Tooooooo gooooood
- Tahniyat said Excellent..the best way to explain.i wish the whole pathoogy explanation would be like this….